Global Sterile Injectables Market Analysis & Forecasts to 2023, With an Expected CAGR of 6.39% - ResearchAndMarkets.com

July 11, 2018

DUBLIN--(BUSINESS WIRE)--Jul 11, 2018--The “Global Sterile Injectables Market - Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.

According to the report the global sterile injectables market is projected to display a robust growth represented by a CAGR of 6.39 % during 2018 - 2023.

Growth of the global sterile injectables market is primarily driven by increasing prevalence of chronic diseases and rapidly increasing ageing population that are highly susceptible to chronic diseases. Moreover, rise in the global healthcare expenditure, changing lifestyle and rising demand for the better quality of life are some of the macro economic factors which impelled the growth of the market.

The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global sterile injectables. Additionally, the report also highlights market entry dynamics for various companies across the globe.

Companies Mentioned

Sanofi Pfizer Baxer International Glaxo smith kline Novartis Gilead Sciences Merck & Co. Astra Zeneca

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4 Sterile Injectables Outlook

5 Global Sterile Injectables: Growth and Forecast

6. Global Sterile Injectables Market - Segment Analysis

7. Global Sterile Injectables Market: Regional Analysis

8. Global Sterile Injectables Market Dynamics

9. Global Sterile Injectables Market Trends

10. Policy and Regulatory Landscape

11. Porter Five Force Analysis

12. SWOT Analysis

13. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/k5vzd4/global_sterile?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180711005339/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infusions and Injectables



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/11/2018 05:44 AM/DISC: 07/11/2018 05:44 AM


Update hourly